Pemigatinib for the Treatment of Myeloid/lymphoid Neoplasms with FGFR1 Rearrangement
EXPERT REVIEW OF ANTICANCER THERAPY（2023）
Key words
Fibroblast growth factor receptor,FGFR1 rearrangement,myeloid,lymphoid neoplasm,eosinophilia,myeloproliferative neoplasm,pemigatinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined